Search Within

Satish K Tickoo

Formats
  1. Meeting Abstract (302)
  2. Journal Article (162)
  3. Review (10)
  4. Book Section (4)
  5. Book Whole (1)
  6. Correspondence (1)
  7. Editorial (1)
  8. Guidelines (1)
  9. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (483)
  2. Surgery (204)
  3. Urology (191)
  4. Department of Medicine (139)
  5. Human Oncology and Pathogenesis Program (139)
  6. Solid Tumor Oncology Division (133)

More Groups

People
  1. Victor Reuter (401)
  2. Hikmat Al-Ahmadie (306)
  3. Samson Fine (304)
  4. Anuradha Gopalan (298)
  5. Yingbei Chen (246)
  6. Sahussapont Sirintrapun (117)

More People

Years
  1. 2025 (10)
  2. 2024 (13)
  3. 2023 (6)
  4. 2022 (32)
  5. 2021 (17)
  6. 2020 (20)

More Years

Publications
  1. Modern Pathology (159)
  2. Laboratory Investigation (147)
  3. American Journal of Surgical Pathology (38)
  4. Journal of Clinical Oncology (18)
  5. Journal of Urology (11)
  6. Histopathology (9)

More Publications

Publishers
  1. Nature Research (159)
  2. Nature Publishing Group (156)
  3. Lippincott Williams & Wilkins (47)
  4. Elsevier Science, Inc. (24)
  5. American Society of Clinical Oncology (19)
  6. Wiley Blackwell (18)

More Publishers

Results (483)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial
    Journal Article

    Feldman, D. R.; Ged, Y.; Lee, C. H.; Knezevic, A.; Molina, A. M.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Murray, S.; Tickoo, S. K.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • RAS/MAPK pathway driver alterations are significantly associated with oncogenic KIT mutations in germ-cell tumors
    Journal Article

    Mata, D. A.; Yang, S. R.; Ferguson, D. C.; Liu, Y.; Sharma, R.; Benhamida, J. K.; Al-Ahmadie, H. A.; Chakravarty, D.; Solit, D. B.; Tickoo, S. K.; more...
    Urology (2020)

    Fulltext@MSK | Save
  • Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer
    Journal Article

    Gupta, S.; Vanderbilt, C.; Abida, W.; Fine, S. W.; Tickoo, S. K.; Al-Ahmadie, H. A.; Chen, Y. B.; Sirintrapun, S. J.; Chadalavada, K.; Nanjangud, G. J.; more...
    Prostate Cancer and Prostatic Diseases (2020)

    Fulltext@MSK | Save
  • Genomic determinants of nested variant urothelial carcinoma
    Meeting Abstract

    Clinton, T. N.; Whiting, K.; Silva, V.; Li, Q.; Almassi, N.; Pietzak, E.; Bagrodia, A.; Cha, E. K.; Dalbagni, G.; Iyer, G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Novel biomarker for MiT family translocation renal cell carcinoma
    Meeting Abstract

    Wang, X.; Gupta, S.; Zhang, Y.; Mannan, R.; Skala, S.; Rangaswamy, R.; Chinnaiyan, A.; Su, F.; Cao, X.; Giordano, T.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Novel biomarker for MiT family translocation renal cell carcinoma
    Meeting Abstract

    Wang, X.; Gupta, S.; Zhang, Y.; Mannan, R.; Skala, S.; Rangaswamy, R.; Chinnaiyan, A.; Su, F.; Cao, X.; Giordano, T.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Homozygous loss of CDKN2A/B and complex genomic alterations observed in locally advanced/metastatic mucinous tubular and spindle cell carcinoma (MTSCC)
    Meeting Abstract

    Yang, C.; Cimera, R.; Sarungbam, J.; Al-Ahmadie, H.; Gopalan, A.; Sirintrapun, S. J.; Fine, S.; Tickoo, S.; Reuter, V.; Zhang, Y.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Genomic landscape of non-invasive urothelial carcinoma of the bladder
    Meeting Abstract

    Kennedy, J.; Clinton, T.; Almassi, N.; Pietzak, E.; Bochner, B.; Fine, S.; Gopalan, A.; Chen, Y. B.; Sarungbam, J.; Sirintrapun, S. J.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Quantification of pattern 4 in patients with highest needle biopsy Gleason score 4+4=8/Grade group 4 is associated with radical prostatectomy downgrading
    Meeting Abstract

    Kopach, P.; Al-Ahmadie, H.; Chen, Y. B.; Gopalan, A.; Sarungbam, J.; Tickoo, S.; Reuter, V.; Fine, S.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • High-grade unclassified renal cell carcinoma with NF2-loss - Morphologic and molecular analysis
    Meeting Abstract

    Kopach, P.; DiNatale, R.; Al-Ahmadie, H.; Fine, S.; Gopalan, A.; Sarungbam, J.; Hakimi, A.; Tickoo, S.; Reuter, V.; Chen, Y. B.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save